ARTICLE | Company News
Medivir, J&J deal
February 21, 2011 8:00 AM UTC
Medivir partnered with Johnson & Johnson's Janssen Pharmaceutica N.V. unit to discover and develop dengue NS3 protease inhibitors to prevent and treat dengue virus infection. Janssen and Medivir will...